E. Novo

机构：University of Turin

发表论文 9 篇 · 总被引 27 次 · h-index 2

代表论文

• The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis (2024 · Molecular Metabolism · 被引 18)
• P265 MICROPARTICLES RELEASED AS A CONSEQUENCE OF LIPID-INDUCED TOXICITY PROMOTE NLRP3 INFLAMMASOME ACTIVATION IN HepG2 CELLS (2014 · Journal of Hepatology · 被引 9)
• SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis (2024 · Journal of Hepatology)
• Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis (2023 · Journal of Hepatology)
• The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment (2023 · SSRN Electronic Journal)
• Selective LXR α intestinal activation reduces hepatic inflammation and fibrosis during the development of chronic liver injury (2020 · Digestive and Liver Disease)